GLP-1 receptor agonists and pancreatic beta cell apoptosis in diabetes mellitus: a systematic review and meta-analysis of preclinical studies.
Quick Facts
What This Study Found
GLP-1 receptor agonists reduced pancreatic beta cell death by about 10 percentage points in preclinical models, supporting the idea that these drugs help preserve insulin-producing cells.
Key Numbers
Pooled mean difference in apoptosis: -0.10 (95% CI -0.15 to -0.05, p = 0.0003). 5 studies included. I-squared = 100% (extreme heterogeneity). Egger's test p = 0.80 (no publication bias detected).
How They Did This
Systematic review and meta-analysis following PRISMA guidelines. Searched Scopus, PubMed, Embase, and Google Scholar. Included preclinical studies of GLP-1 RA effects on human beta cell apoptosis. Random-effects model.
Why This Research Matters
Diabetes involves the gradual loss of beta cells that make insulin. If GLP-1 drugs can slow this loss, they may do more than just control blood sugar. They could help protect the pancreas itself.
What This Study Doesn't Tell Us
Only five studies met criteria. Extreme heterogeneity (I-squared = 100%) limits confidence in the pooled estimate. All preclinical data from cell cultures. No human clinical evidence. Long-term effects on beta cell function unknown.
Trust & Context
- Original Title:
- GLP-1 receptor agonists and pancreatic beta cell apoptosis in diabetes mellitus: a systematic review and meta-analysis of preclinical studies.
- Published In:
- Frontiers in clinical diabetes and healthcare, 6, 1579961 (2025)
- Authors:
- Rea, Nicolas, Ramdass, Prakash V A K
- Database ID:
- RPEP-13222
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13222APA
Rea, Nicolas; Ramdass, Prakash V A K. (2025). GLP-1 receptor agonists and pancreatic beta cell apoptosis in diabetes mellitus: a systematic review and meta-analysis of preclinical studies.. Frontiers in clinical diabetes and healthcare, 6, 1579961. https://doi.org/10.3389/fcdhc.2025.1579961
MLA
Rea, Nicolas, et al. "GLP-1 receptor agonists and pancreatic beta cell apoptosis in diabetes mellitus: a systematic review and meta-analysis of preclinical studies.." Frontiers in clinical diabetes and healthcare, 2025. https://doi.org/10.3389/fcdhc.2025.1579961
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 receptor agonists and pancreatic beta cell apoptosis i..." RPEP-13222. Retrieved from https://rethinkpeptides.com/research/rea-2025-glp1-receptor-agonists-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.